Fortis Healthcare Ltd on Tuesday announced a net profit of Rs 32.06 crore for the quarter ended September 30, as against a loss of Rs 28.43 crore in the corresponding three-month period of last year.

Fortis' net profit increased despite a considerable decline in its net sales. During the July-September quarter of current fiscal, the company's net sales slipped to Rs 1,281 crore, from Rs 1,493 crore in the year-ago period. The healthcare company attributed the impressive quarterly profit to its focus on the India business.

In the past few months, Fortis sold is assets in foreign markets like Australia, Vietnam and Hong Kong, so that it could focus more on its domestic business.

Commenting on the quarterly results, Fortis CEO Vishal Bali, "Our results for the quarter strongly reflect the focus of the company on the India business... We will pursue both greenfield and brownfield capacity expansion to continue our growth trajectory and market leadership in India."

Fortis' consolidated India business revenues in the quarter under review were recorded at Rs 879 crore, its global operation revenues stood at Rs 402 crore, accounting for 31 per cent to the company's consolidated revenues. The company now aims to generate nearly 95 per cent of its total revenues from its Indian operations.

Stock in Fortis Healthcare ended its Tuesday's trading at Rs 97.90 a share, down 2.44 per cent from the previous close, on the Bombay Stock Exchange (BSE).